|
64Cu-DOTA-ECL1i Clinical Trials
1 actively recruiting trial across 1 location
Also known as: 64Cu-d(LGTFLKC), Copper Cu 64-DOTA-ECL1i, Cu-64 DOTA-ECL1i
Pipeline
Phase 2: 1
Top Sponsors
- Washington University School of Medicine1
Indications
- Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)1
- Head and Neck Squamous Cell Carcinoma (HNSCC)1
- Head and Neck Squamous Cell Carcinoma1
- Cancer1
St Louis, Missouri1 trial
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.